Breaking News Instant updates and real-time market news.

WBA

Walgreens Boots Alliance

$54.33

1.93 (3.68%)

, MNK

Mallinckrodt

$8.89

0.39 (4.59%)

09:55
06/27/19
06/27
09:55
06/27/19
09:55

Early notable gainers among liquid option names on June 27th

Notable gainers among liquid option names this morning include Walgreen Boots (WBA) $54.75 +2.36, Mallinckrodt (MNK) $8.89 +0.37, Ryder (R) $57.13 +1.82, American Airlines (AAL) $32.49 +1.03, and CenturyLink (CTL) $11.21 +0.30.

WBA

Walgreens Boots Alliance

$54.33

1.93 (3.68%)

MNK

Mallinckrodt

$8.89

0.39 (4.59%)

R

Ryder

$56.40

1.09 (1.97%)

AAL

American Airlines

$32.18

0.715 (2.27%)

CTL

CenturyLink

$11.25

0.34 (3.12%)

  • 27

    Jun

  • 30

    Jul

  • 09

    Sep

  • 13

    Nov

  • 14

    Nov

WBA Walgreens Boots Alliance
$54.33

1.93 (3.68%)

05/14/19
RAJA
05/14/19
NO CHANGE
RAJA
Walgreens could target Amerisource, LabCorp if it seeks M&A, says Raymond James
Raymond James analyst John Ransom said he thinks that "the temptation" for Walgreens (WBA) to do "something" in terms of M&A will grow over time and the "something" it may consider could include either acquiring AmerisourceBergen (ABC) or LabCorp (LH). His analysis points to LabCorp being a less complicated, "but much less accretive," deal, said Ransom. Given Walgreens' existing ownership of about a 26% stake in AmerisourceBergen, he estimates 16% accretion from buying the company for $95 per share in cash if he assumes $500M of synergies and $2B of opioid fines financed with debt, the analyst tells investors. Though such a deal would make financial sense, he does not think investors would "be overly excited about the strategic upside," Ransom tells investors. While he argues that LabCorp "offers more strategic upside," such a hypothetical deal also has less financial benefit, according to Ransom.
04/25/19
DESJ
04/25/19
INITIATION
DESJ
Buy
Desjardins initiates HEXO Corp, Canopy Growth, Aurora Cannabis with a Buy
Desjardins analyst John Chu initiated HEXO Corp (HEXO), Canopy Growth (CGC), and Aurora Cannabis (ACB) with a Buy rating and respective price targets of C$14, C$74, and C$16.50 as part of a broad research note, saying the "hype" around legalization of adult-use cannabis in Canada remains strong in spite of "underwhelming" early months of sales. The analyst attributes the challenges to ramp-up, logistical and distribution issues, but expects investors to consider the opportunity as a "global" one. Chu believes that "major" consumer packaged goods companies like Constellation (STZ), InBev (BUD), and Altria (MO), as well as retailers like Walgreens (WBA), CVS (CVS), and Rite Aid (RAD) should "help push cannabis and hemp into the mainstream."
04/25/19
BARD
04/25/19
NO CHANGE
Target $336
BARD
Outperform
Smile Direct, CVS news 'good' for Align Technology, says Baird
Smile Direct Club announced an expanded agreement with CVS (CVS) and an agreement with Aetna Dental, which Baird analyst Jeff Johnson could likely drive additional clear aligner awareness, something that should be good for the industry, and, specifically Align Technology (ALGN), where early efforts with Walgreens (WBA) "seem to be developing" and where traction remains strong through DSOs. The analyst maintains an Outperform rating and $336 price target on Align Technology shares.
04/18/19
04/18/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Morgan Stanley (MS) downgraded to Neutral from Buy at Citi with analyst Keith Horowitz saying Morgan Stanley reported "strong" Q1 results but the shares are fairly valued. 2. Snap (SNAP) downgraded to Negative from Mixed at Vertical Group and to Neutral from Outperform at Wedbush. 3. Rite Aid (RAD) downgraded with a Sell from Neutral at Guggenheim while Walgreens Boots Alliance (WBA) was downgraded with a Neutral from Buy. 4. CF Industries (CF) downgraded to Underperform from Buy at BofA/Merrill with analyst Steve Byrne saying he has spoken with 10 key channel contacts in the Cornbelt and several commented that never in their 30-plus year careers have they seen fertilizer applications this far behind, mainly due to the weather. 5. FMC Corporation (FMC) downgraded to Sector Perform from Outperform at RBC Capital with analyst Arun Viswanathan citing the "uncertainty of Rynaxypyr and Cyazypyr patent expiration" as well as the reduced multiple from the recent lithium separation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
MNK Mallinckrodt
$8.89

0.39 (4.59%)

06/11/19
LEHM
06/11/19
INITIATION
Target $11
LEHM
Equal Weight
Mallinckrodt initiated with an Equal Weight at Barclays
Barclays analyst Balaji Prasad started Mallinckrodt with an Equal Weight rating and $11 price target. The analyst launched coverage of 20 U.S. Specialty Pharmaceuticals with a Neutral industry view. He placed importance on cash flows and companies' ability to manage leverage and improve balance sheets.
06/12/19
CANT
06/12/19
NO CHANGE
Target $18
CANT
Overweight
Mallinckrodt price target lowered to $18 from $42 at Cantor Fitzgerald
Cantor Fitzgerald analyst Louise Chen lowered her price target for Mallinckrodt to $18 from $42, driven by multiple contraction, given increasing headwinds from macro factors. While acknowledging that competition for Acthar could drive downside to her estimates and the consensus, the analyst reiterates an Overweight rating on the shares.
06/13/19
STFL
06/13/19
NO CHANGE
Target $24
STFL
Hold
Mallinckrodt's Acthar Phase 4 data shows 'strong' evidence in RA, says Stifel
Stifel analyst Annabel Samimy maintained a Hold rating and $24 price target on Mallinckrodt after the company released the full release of its two-part Phase 4 study of Acthar in refractory patients with persistent Rheumatoid Arthritis at EULAR, noting that both parts of the study hit all primary and secondary endpoints. In a research note to investors, Samimy says with these data that show "strong" clinical evidence in RA, she sees opportunity for Mallinckrodt to have more meaningful clinical discussions in third-party payer negotiations and greater validation with Medicare, both of which could support Acthar volumes going forward.
06/14/19
ADAM
06/14/19
NO CHANGE
Target $22
ADAM
Buy
Mallinckrodt price target lowered to $22 from $37 at Canaccord
Canaccord analyst Dewey Steadman lowered his price target on Mallinckrodt to $22 from $37 following the company's release of a blinded RA study showing Acthar's effectiveness. The analyst noted the data is the first of a string of expected Acthar data reads that he thinks can bolster and justify Acthar's use for exacerbations in highly refractory immune-modulated conditions. The price target reduction is based on a lower expected contribution from pipeline products. Steadman maintained his Buy rating on Mallinckrodt shares.
R Ryder
$56.40

1.09 (1.97%)

11/29/18
STFL
11/29/18
UPGRADE
Target $69
STFL
Buy
Ryder upgraded to Buy from Hold at Stifel
Stifel analyst David Ross upgraded Ryder System to Buy while lowering his price target for the shares to $69 from $81. Approaching 2019, the stock's upside/ downside case is now in investors' favor, Ross tells investors in a research note. He says that while estimates have been cut, Ryder's valuation is more reasonable at current levels. With the trucking market expected to remain tight in 2019, commercial rental demand should firm, says the analyst. Ross cites valuation for the upgrade of Ryder to Buy.
11/29/18
11/29/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. McDonald's (MCD) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst John Glass saying he expects the benefits from the company's U.S. store remodeling to become apparent in 2019. 2. TJX (TJX) upgraded to Buy from Hold at Argus with analyst Chris Graja saying the rating change is driven by the pullback in the stock price given the company's growing store traffic, single-A credit ratings, and a 22% annualized dividend growth. 3. Ryder (R) upgraded to Buy from Hold at Stifel with analyst David Ross saying approaching 2019, the stock's upside/downside case is now in investors' favor. 4. Dominion (D) upgraded to Buy from Neutral at UBS with analyst Daniel Ford saying management has taken "appropriate and necessary" actions to overcome the negative impact of the surprise master limited partnership income tax ruling that the Federal Energy Regulatory Commission issued earlier this year. 5. PPG (PPG) upgraded to Buy from Neutral at Citi analyst P.J. Juvekar saying "rapidly falling" oil prices are poised to reduce some of the raw material inflation pressuring the company. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/12/18
RHCO
12/12/18
INITIATION
RHCO
Buy
Ryder initiated with a Buy at SunTrust
SunTrust analyst Stephanie Benjamin initiated Ryder with a Buy rating and $63 price target.
12/13/18
RHCO
12/13/18
INITIATION
Target $63
RHCO
Buy
Ryder initiated with a Buy at SunTrust
As reported yesterday, SunTrust analyst Stephanie Benjamin initiated Ryder with a Buy rating and a $63 price target. The analyst believes that the growth prospects of the company's "transportation outsourcing business and the size of the addressable market are underappreciated by the Street." Benjamin expects Ryder to exceed its current expectations with continued generation of "double-digit revenue and at least high-single-digit earnings growth trajectory over the next few years."
AAL American Airlines
$32.18

0.715 (2.27%)

05/20/19
05/20/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. American Airlines (AAL) downgraded to Underweight from Equal Weight at Morgan Stanley while Delta Air Lines (DAL) was downgraded to Equal Weight from Overweight. 2. Deutsche Bank (DB) downgraded to Sell from Neutral at UBS with the firm saying the bank is facing limited strategic options and its operating conditions are unlikely to improve in the near term amid intense competition. 3. Eaton Vance (EV) double downgraded to Underperform from Buy at BofA/Merrill with analyst Michael Carrier lowering estimates to reflect slower flow trends, a difficult product mix, and potential margin pressures ahead. 4. ProAssurance (PRA) downgraded to Underperform from Market Perform at Keefe Bruyette with analyst Christopher Campbell saying the stock has rallied 9% since the company's "disappointing" Q1 results. 5. Clorox (CLX) downgraded to Hold from Buy at Argus with analyst John Staszak citing the company's revenue deceleration reported in Q3 to "just 2%" as well as its near-term growth outlook cut to 2%-3% from 2%-4%. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/13/19
JPMS
06/13/19
NO CHANGE
JPMS
JPMorgan notes airline fare hike, doesn't see domestic 'resilience' as priced in
JPMorgan analyst Jamie Baker said he was "surprised" to see domestic fares rising again after a price hike five weeks ago, noting that Southwest (LUV) joined with an increase overnight. Given "the crescendo of inquiries as to why, and nary a question on fares," Baker said he is confident that increased domestic fare resilience is not yet priced into airline stocks. Other publicly traded airlines include Alaska Air (ALK), American Airlines (AAL), Delta Air Lines (DAL), JetBlue (JBLU), Spirit Airlines (SAVE) and United Continental (UAL).
06/13/19
JPMS
06/13/19
NO CHANGE
JPMS
American, Southwest raised domestic rates in last two days, says JPMorgan
JPMorgan analyst Jamie Baker said American Airlines (AAL) took a "plain vanilla" domestic fare increase of $5 one-way yesterday morning, which was followed by what looks like a system-wide increase from Hawaiian (HA) and a "substantive" Lower 48 increase from Southwest (LUV). He was not expecting another increase so soon after the industry took a broad-based domestic increase in the second week of May, noted Baker, who thinks evidence of domestic demand and potential Q2 guidance increases could reverse "recent apathy" towards the airline space. Other publicly traded airlines include Alaska Air (ALK), American Airlines (AAL), Delta Air Lines (DAL), JetBlue (JBLU), Southwest (LUV), Spirit Airlines (SAVE) and United Continental (UAL).
06/05/19
STPT
06/05/19
INITIATION
STPT
Buy
American Airlines initiated with a Buy at Standpoint Research
CTL CenturyLink
$11.25

0.34 (3.12%)

05/23/19
GUGG
05/23/19
UPGRADE
Target $10
GUGG
Neutral
CenturyLink upgraded to Neutral on valuation at Guggenheim
Guggenheim analyst Mike McCormack upgraded CenturyLink to Neutral from Sell with the shares below his price target of $10. Despite the continued challenging fundamental backdrop, CenturyLink shares offer a more balanced risk/reward after declining 34% year-to-date, McCormack tells investors in a research note. While the analyst finds it unlikely that the company's Consumer business will get sold, he believes management is appropriately running the unit for cash as de-levering continues.
06/26/19
WELS
06/26/19
UPGRADE
WELS
Outperform
CenturyLink upgraded to Outperform from Market Perform at Wells Fargo
06/27/19
WELS
06/27/19
UPGRADE
Target $14
WELS
Outperform
Wells Fargo upgrades CenturyLink to Outperform, sees 28% upside potential
Wells Fargo analyst Jennifer Fritzsche last night upgraded CenturyLink to Outperform from Market Perform and raised her price target for the shares to $14 from $12. The stock closed yesterday up 16c to $10.91. The company's evolution is showing more of the "fiber roots" that came from the Level 3 side of the business and will continue to include both dark fiber and wireless in its approach, Fritzsche tells investors in a research note. She views this move positively and believes it is underappreciated by the Street. Investors appear to be giving CenturyLink essentially no credit to see a back half of 2019 improvement, which is achievable given the "intense fiber centric focus it is now undertaking," adds the analyst. Fritzsche sees 28% potential upside in the shares.
05/23/19
GUGG
05/23/19
UPGRADE
GUGG
Neutral
CenturyLink upgraded to Neutral from Sell at Guggenheim

TODAY'S FREE FLY STORIES

VNO

Vornado

$65.42

-0.06 (-0.09%)

10:49
07/16/19
07/16
10:49
07/16/19
10:49
Hot Stocks
Vornado sees 5c decrease in Q2 FFO due to certain items »

Vornado Realty Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

  • 07

    Aug

CCJ

Cameco

$10.24

0.03 (0.29%)

10:45
07/16/19
07/16
10:45
07/16/19
10:45
Options
Cameco call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:45
07/16/19
07/16
10:45
07/16/19
10:45
General news
Breaking General news story  »

8-Week Bill Announcement…

10:45
07/16/19
07/16
10:45
07/16/19
10:45
General news
Breaking General news story  »

4-Week Bill Announcement…

WFC

Wells Fargo

$46.25

-0.45 (-0.96%)

10:41
07/16/19
07/16
10:41
07/16/19
10:41
Hot Stocks
Breaking Hot Stocks news story on Wells Fargo »

Wells Fargo sees FY19,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 12

    Oct

SNE

Sony

$54.33

-1.44 (-2.58%)

10:35
07/16/19
07/16
10:35
07/16/19
10:35
Options
Sony put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

WFC

Wells Fargo

$46.55

-0.15 (-0.32%)

10:33
07/16/19
07/16
10:33
07/16/19
10:33
Hot Stocks
Breaking Hot Stocks news story on Wells Fargo »

Wells Fargo CFO says 38…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 12

    Oct

GCAP

Gain Capital

$4.54

0.51 (12.66%)

10:29
07/16/19
07/16
10:29
07/16/19
10:29
Hot Stocks
Gain Capital up 50c, or 12%, to $4.53 in early trading »

Contacts have indicated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

WFC

Wells Fargo

$46.88

0.18 (0.39%)

10:27
07/16/19
07/16
10:27
07/16/19
10:27
Hot Stocks
Breaking Hot Stocks news story on Wells Fargo »

Wells Fargo sees FY19…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 12

    Oct

WFC

Wells Fargo

$46.88

0.18 (0.39%)

10:26
07/16/19
07/16
10:26
07/16/19
10:26
Hot Stocks
Wells Fargo sees FY19 NII down near 5% »

Management says auto…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 12

    Oct

KMX

CarMax

$84.47

-4.31 (-4.85%)

10:25
07/16/19
07/16
10:25
07/16/19
10:25
Options
CarMax call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

EGHT

8x8, Inc.

$25.38

-0.24 (-0.94%)

, FIVN

Five9

$50.13

2.13 (4.44%)

10:25
07/16/19
07/16
10:25
07/16/19
10:25
Conference/Events
Stephens communications analysts to hold an analyst/industry conference call »

Communications Analysts,…

EGHT

8x8, Inc.

$25.38

-0.24 (-0.94%)

FIVN

Five9

$50.13

2.13 (4.44%)

LOGM

LogMeln

$76.20

-0.37 (-0.48%)

RNG

RingCentral

$124.44

1.13 (0.92%)

WORK

Slack Technologies

$34.84

0.06 (0.17%)

TWLO

Twilio

$147.01

1.655 (1.14%)

VG

Vonage

$12.82

0.03 (0.23%)

ZM

Zoom Video

$98.50

-1.26 (-1.26%)

GOOG

Alphabet

$1,150.69

0.3 (0.03%)

MSFT

Microsoft

$138.20

-0.74 (-0.53%)

AMZN

Amazon.com

$2,019.00

-2 (-0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 17

    Jul

  • 18

    Jul

  • 25

    Jul

  • 25

    Jul

  • 25

    Jul

  • 30

    Jul

  • 31

    Jul

  • 01

    Aug

  • 06

    Aug

  • 08

    Aug

  • 08

    Aug

  • 27

    Oct

  • 13

    Nov

UBER

Uber

$44.49

-0.02 (-0.04%)

, LYFT

Lyft

$64.80

(0.00%)

10:22
07/16/19
07/16
10:22
07/16/19
10:22
Periodicals
Court says NYC can ban ads inside Uber, Lyft vehicles, Reuters reports »

Reversing a lower court…

UBER

Uber

$44.49

-0.02 (-0.04%)

LYFT

Lyft

$64.80

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

  • 08

    Aug

  • 08

    Aug

FCAU

Fiat Chrysler

$13.61

-0.565 (-3.99%)

, WORK

Slack Technologies

$34.75

-0.03 (-0.09%)

10:20
07/16/19
07/16
10:20
07/16/19
10:20
Initiation
Fly Intel: Top five analyst initiations »

Catch up on today's…

FCAU

Fiat Chrysler

$13.61

-0.565 (-3.99%)

WORK

Slack Technologies

$34.75

-0.03 (-0.09%)

BTE

Baytex Energy

$1.47

0.03 (2.08%)

TOWN

TowneBank

$26.85

(0.00%)

VET

Vermilion Energy

$21.76

-0.2 (-0.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 29

    Jul

  • 31

    Jul

  • 11

    Sep

HD

Home Depot

$218.16

-0.55 (-0.25%)

, SON

Sonoco

$64.48

-0.005 (-0.01%)

10:20
07/16/19
07/16
10:20
07/16/19
10:20
Downgrade
Fly Intel: Top five analyst downgrades »

Catch up on today's…

HD

Home Depot

$218.16

-0.55 (-0.25%)

SON

Sonoco

$64.48

-0.005 (-0.01%)

PH

Parker-Hannifin

$172.01

4.33 (2.58%)

FDS

FactSet

$281.22

-13.02 (-4.43%)

KMT

Kennametal

$35.09

0.295 (0.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 17

    Jul

  • 18

    Jul

  • 01

    Aug

  • 06

    Aug

  • 12

    Aug

  • 20

    Aug

  • 20

    Aug

  • 17

    Oct

LH

LabCorp

$174.70

0.155 (0.09%)

, TKR

Timken

$48.61

0.92 (1.93%)

10:20
07/16/19
07/16
10:20
07/16/19
10:20
Upgrade
Fly Intel: Top five analyst upgrades »

Catch up on today's…

LH

LabCorp

$174.70

0.155 (0.09%)

TKR

Timken

$48.61

0.92 (1.93%)

FCX

Freeport McMoRan

$11.23

0.09 (0.81%)

WPM

Wheaton Precious Metals

$24.45

0.27 (1.12%)

OMF

OneMain Holdings

$35.07

1.135 (3.34%)

NOK

Nokia

$5.15

0.045 (0.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 25

    Jul

  • 30

    Jul

  • 31

    Jul

  • 06

    Aug

  • 09

    Aug

  • 09

    Sep

10:20
07/16/19
07/16
10:20
07/16/19
10:20
General news
The June U.S. industrial production report tracked estimates »

The June U.S. industrial…

10:20
07/16/19
07/16
10:20
07/16/19
10:20
General news
The May U.S. business inventory report tracked estimates »

The May U.S. business…

RTN

Raytheon

$178.96

0.88 (0.49%)

10:19
07/16/19
07/16
10:19
07/16/19
10:19
Hot Stocks
Raytheon submits Lower Tier Air and Missile Defense Sensor proposal to U.S. Army »

Raytheon Company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
07/16/19
07/16
10:17
07/16/19
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
07/16/19
07/16
10:16
07/16/19
10:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LB

L Brands

$26.70

(0.00%)

10:15
07/16/19
07/16
10:15
07/16/19
10:15
Periodicals
L Brands CEO says not aware of Jeffrey Epstein's behavior, WSJ reports »

In a memo to employees on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

IQ

iQIYI

$18.97

-0.52 (-2.67%)

10:15
07/16/19
07/16
10:15
07/16/19
10:15
Options
iQiyi put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EVLO

Evelo Biosciences

$7.66

(0.00%)

10:13
07/16/19
07/16
10:13
07/16/19
10:13
Hot Stocks
Breaking Hot Stocks news story on Evelo Biosciences »

Evelo Biosciences Inc…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

10:10
07/16/19
07/16
10:10
07/16/19
10:10
General news
U.S. July NAHB housing market index rebounded 1 point to 65 »

U.S. July NAHB housing…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.